In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Telomerase is a specialized reverse transcriptase responsible for the de novo synthesis of telomeric DNA repeats. In addition to its established reverse transcriptase and terminal transferase activities, recent reports have revealed unexpected cellular activities of telomerase, including RNA-dependent RNA polymerization. This telomerase characteristic, distinct from other reverse transcriptases, indicates that clinically relevant reverse transcriptase inhibitors might have unexpected telomerase inhibition profiles. This is particularly important for the newer generation of RT inhibitors designed for anti-HIV therapy, which have reported higher safety margins than older agents. Using an in vitro primer extension assay, we tested the effects of clinically relevant HIV reverse transcriptase inhibitors on cellular telomerase activity. We observed that all commonly used nucleoside reverse transcriptase inhibitors (NRTIs), including zidovudine, stavudine, tenofovir, didanosine and abacavir, inhibit telomerase effectively in vitro. Truncated telomere synthesis was consistent with the expected mode of inhibition by all tested NRTIs. Through dose-response experiments, we established relative inhibitory potencies of NRTIs on in vitro telomerase activity as compared to the inhibitory potencies of the corresponding dideoxynucleotide triphosphates. In contrast to NRTIs, the non-nucleoside reverse transcriptase inhibitors (NNRTIs) nevirapine and efavirenz did not inhibit the primer extension activity of telomerase, even at millimolar concentrations. Long-term, continuous treatment of human HT29 cells with select NRTIs resulted in an accelerated loss of telomere repeats. All tested NRTIs exhibited the same rank order of inhibitory potencies on telomerase and HIV RT, which, according to published data, were orders-of-magnitude more sensitive than other DNA polymerases, including the susceptible mitochondria-specific DNA polymerase gamma. We concluded that telomerase activity could be inhibited by common NRTIs, including currently recommended RTI agents tenofovir and abacavir, which warrants large-scale clinical and epidemiological investigation of the off-target effects of long-term highly active antiretroviral therapy (HAART) with these agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Contrastingly, other studies have suggested that the use of NRTIs may potentially activate the tumour suppressor gene p53 in healthy cells, inhibiting telomerase to cause cell death [183,184,185].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“Moreover, NRTIs can also inhibit telomerase and are thought to contribute to accelerated aging phenotypes associated with HIV patients (Hukezalie et al., 2012; Leeansyah et al., 2013).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Hukezalie et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“The catalytic core of the telomerase enzyme is a ribonucleoprotein composed of telomerase reverse transcriptase (TERT), the catalytic subunit [5], and telomerase RNA (TER) [6].”
BackgroundCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096 · cited 1×
“When telomeres reach a critical length, cellular surveillance mechanisms are activated and cellular proliferation ceases, either by permanent cell-cycle arrest, known as senescence, or by apoptosis [2,3].”
BackgroundHow Shelterin Protects Mammalian Telomeres
Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802
Thompson, M. A., Aberg, J. A., Cahn, P., Montaner, J. S. G., Rizzardini, G., Telenti, A., Gatell, J. M., Günthard, H. F., Hammer, S. M., Hirsch, M. S., et al. (2010) · JAMA · doi:10.1001/jama.2010.1004 · Cited by 722
Effros, R. B., Fletcher, C. V., Gebo, K., Halter, J. B., Hazzard, W. R., Horne, F. M., Huebner, R. E., Janoff, E. N., Justice, A. C., Kuritzkes, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590150 · Cited by 539
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Maida, Y., Yasukawa, M., Furuuchi, M., Lassmann, T., Possemato, R., Okamoto, N., Kasim, V., Hayashizaki, Y., Hahn, W. C., & Masutomi, K. (2009) · Nature · doi:10.1038/nature08283 · Cited by 384
Haendeler, J., Dröse, S., Büchner, N., Jakob, S., Altschmied, J., Goy, C., Spyridopoulos, I., Zeiher, A. M., Brandt, U., & Dimmeler, S. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185546 · Cited by 375
The human CST complex is a terminator of telomerase activity
Chen, L.-Y., Redon, S., & Lingner, J. (2012) · Nature · doi:10.1038/nature11269 · Cited by 348
Strahl, C., & Blackburn, E. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.53 · Cited by 335 · cited 1×
“In immortalized human T- and B-lymphocyte cell lines, AZT, but not d4T, caused telomere shortening, and AZT-TP inhibited human telomerase in vitro [7].”
BackgroundTelomerase: An RNP Enzyme Synthesizes DNA
Blackburn, E. H., & Collins, K. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003558 · Cited by 335
Vince, R., Hua, M., Brownell, J., Daluge, S., Lee, F., Shannon, W. M., Lavelle, G. C., Qualls, J., Weislow, O. S., Kiser, R., et al. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80950-1 · Cited by 232
Olivero, O. A., Yuspa, S. H., Poirier, M. C., Anderson, L. M., Jones, A. B., Wang, C., Diwan, B. A., Haines, D. C., Logsdon, D., Harbaugh, S. W., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1602 · Cited by 225
Sluis-Cremer, N., Temiz, N., & Bahar, I. (2004) · Current HIV Research · doi:10.2174/1570162043351093 · Cited by 142
Telomerase, mitochondria and oxidative stress
Saretzki, G. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.05.004 · Cited by 128
Cihlář, T., Birkuš, G., Greenwalt, D. E., & Hitchcock, M. J. M. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00210-8 · Cited by 123
Capeau, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir628 · Cited by 118
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors
Olivero, O. A. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20195 · Cited by 115
Kovalenko, O. A., Caron, M. J., Ulema, P., Medrano, C., Thomas, A. P., Kimura, M., Bonini, M. G., Herbig, U., & Santos, J. H. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00551.x · Cited by 108
Irreversible Telomere Shortening by 3′-Azido-2′, 3′-Dideoxythymidine (AZT) Treatment
Gomez, D. E., Tejera, Á. M., & Olivero, O. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8555 · Cited by 82
Telomeres, telomerase, and apoptosis
Mondello, C., & Scovassi, A. I. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-048 · Cited by 73
Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase
Kopera, H. C., Moldovan, J. B., Morrish, T. A., Garcia-Perez, J. L., & Moran, J. V. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100275108 · Cited by 66
Fang, J., & Beland, F. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp136 · Cited by 66
Meng, Q. R., Walker, D. M., Olivero, O. A., Shi, X., Antiochos, B., Poirier, M. C., & Walker, V. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220203197 · Cited by 65
RMRP Is a Non-Coding RNA Essential for Early Murine Development
Rosenbluh, J., Nijhawan, D., Chen, Z., Wong, K., Masutomi, K., & Hahn, W. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026270 · Cited by 63
HIV treatment as prevention among injection drug users
Wood, E., Milloy, M., & Montaner, J. S. G. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834f9927 · Cited by 62
Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line
Brown, T. A., Sigurdson, E. R., Rogatko, A., & Broccoli, D. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.032 · Cited by 60
Tamakawa, R., Fleisig, H. B., & Wong, J. M. Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2227 · Cited by 58
Self-citationTelomerase and retrotransposons: Reverse transcriptases that shaped genomes
Belfort, M., Curcio, M. J., & Lue, N. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100269109 · Cited by 50
Telomerase can act as a template- and RNA-independent terminal transferase
Lue, N. F., Bosoy, D., Moriarty, T. J., Autexier, C., Altman, B., & Leng, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502252102 · Cited by 49
Prescott, J. C., & Blackburn, E. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2941-2948.2000 · Cited by 49
Non-telomeric activities of telomerase
Majerská, J., Sýkorová, E., & Fajkus, J. (2011) · Molecular BioSystems · doi:10.1039/c0mb00268b · Cited by 48
The Emerging Role of Telomerase Reverse Transcriptase in Mitochondrial DNA Metabolism
Gordon, D. M., & Santos, J. H. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/390791 · Cited by 47
Rossi, A., Russo, G. M., Puca, A., Montagna, R. L., Caputo, M., Mattioli, E., Lopez, M., Giordano, A., & Pentimalli, F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24331 · Cited by 47
Bailey, C. M., Kasiviswanathan, R., Copeland, W. C., & Anderson, K. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01659-08 · Cited by 44
Ray, A. S., Yang, Z., Shi, J., Hobbs, A. W., Schinazi, R. F., Chu, C. K., & Anderson, K. S. (2002) · Biochemistry · doi:10.1021/bi0121858 · Cited by 42
Liu, X., Takahashi, H., Harada, Y., Ogawara, T., Ogimura, Y., Mizushina, Y., Saneyoshi, M., & Yamaguchi, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm859 · Cited by 39
Painter, G. R., Almond, M. R., Mao, S., & Liotta, D. C. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043388358 · Cited by 39
Eckert, B., & Collins, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339853 · Cited by 35
Ji, H. J., Rha, S. Y., Jeung, H., Yang, S., An, S. W., & Chung, H. C. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-5156-0 · Cited by 34
Interaction of Deoxyguanosine Nucleotide Analogs with Human Telomerase
Tendian, S. W., & Parker, W. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.695 · Cited by 34
Brown, J. A., Pack, L. R., Fowler, J. D., & Suo, Z. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01229-10 · Cited by 31
Zeng, X., Thumati, N. R., Fleisig, H. B., Hukezalie, K. R., Savage, S. A., Giri, N., Alter, B. P., & Wong, J. M. Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr504 · Cited by 28
Self-citationIntracellular Activation of 2',3'-Dideoxyinosine and Drug Interactions in Vitro
Kewn, S., Hoggard, P. G., Henry-Mowatt, J., Veal, G. J., Sales, S. D., Barry, M. G., & Back, D. J. (1999) · AIDS Research and Human Retroviruses · doi:10.1089/088922299310692 · Cited by 26
Yang, G., Wang, J., Cheng, Y., Dutschman, G. E., Tanaka, H., Baba, M., & Cheng, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00083-08 · Cited by 19
Human inter-individual variability in metabolism and genotoxic response to zidovudine
Olivero, O. A., MING, J., DAS, S., Vazquez, I. L., RICHARDSON, D., WESTON, A., & Poirier, M. C. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.005 · Cited by 8
Brás, A., & Rueff, J. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.12.006 · Cited by 4
Ray, A. S., Feng, J. Y., Murakami, E., Chu, C. K., Schinazi, R. F., & Anderson, K. S. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800103 · Cited by 4
Cited by
LINE1 Derepression in aged wild-type and SIRT6-deficient mice drives inflammation
Simon, M., Van Meter, M., Ablaeva, J., Ke, Z., Gonzalez, R. S., Taguchi, T., De Cecco, M., Leonova, K. I., Kogan, V., Helfand, S. L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.014 · Cited by 498
Cytoplasmic DNA: sources, sensing, and role in aging and disease
Miller, K. N., Victorelli, S. G., Salmonowicz, H., Dasgupta, N., Liu, T., Passos, J. F., & Adams, P. D. (2021) · Cell · doi:10.1016/j.cell.2021.09.034 · Cited by 288
Oxidative guanine base damage regulates human telomerase activity
Fouquerel, E., Lormand, J., Bose, A., Lee, H.-T., Kim, G. S., Li, J., Sobol, R. W., Freudenthal, B. D., Myong, S., & Opresko, P. L. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3319 · Cited by 182
The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging
Schank, M., Zhao, J., Moorman, J. P., & Yao, Z. Q. (2021) · Cells · doi:10.3390/cells10010174 · Cited by 171
New prospects for targeting telomerase beyond the telomere
Arndt, G. M., & MacKenzie, K. L. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.55 · Cited by 131
Metadata
- Authors
- Hukezalie, K. R., Thumati, N. R., Côté, H. C. F., & Wong, J. M. Y.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Wong, Judy M. Y.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-11-15
- Volume
- 7
- Issue
- 11
- Pages
- e47505
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3499584
- OpenAlex
- W2149868956
- Cited by
- 84
- References
- 50
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 10 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 7 · 2015: 2 · 2014: 8 · 2013: 5
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Michael Smith Health Research BC
- National Institutes of Health
- Canadian Institutes of Health Research (551_5)
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- telomerase inhibition, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, HIV reverse transcriptase, off-target effects, tenofovir, abacavir, antiretroviral therapy, zidovudine, stavudine, didanosine, nevirapine, efavirenz, primer extension assay
- MeSH terms
- Tenofovir, Abacavir, Adenine, Alkynes, Cell Line, Cyclopropanes, Dose-Response Relationship, Drug, Humans, Zidovudine, Dideoxynucleosides, Didanosine, DNA Primers, Stavudine, Reverse Transcriptase Inhibitors, Telomerase, Anti-HIV Agents, Nevirapine, Benzoxazines, Organophosphonates, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.